Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
269.00
+14.00 (5.49%)
Mar 5, 2026, 1:35 PM CST

Lotus Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
70,74271,52471,93564,46225,56919,628
Market Cap Growth
0.21%-0.57%11.59%152.11%30.27%-29.79%
Enterprise Value
77,48880,27681,66671,66030,85125,397
Last Close Price
269.00262.47260.17232.5690.8474.29
PE Ratio
14.9114.1217.5221.3418.2219.12
Forward PE
10.2012.0515.3618.3915.4116.33
PS Ratio
3.793.854.244.412.021.83
PB Ratio
3.193.384.154.652.312.24
P/TBV Ratio
7.067.2611.6528.1410.18-
P/FCF Ratio
9.6512.3359.7720.52-12.79
P/OCF Ratio
9.2111.6244.5617.33213.6810.07
EV/Sales Ratio
4.154.324.824.902.442.37
EV/EBITDA Ratio
11.0810.9513.2314.079.6310.74
EV/EBIT Ratio
13.8612.9916.0716.8612.2014.59
EV/FCF Ratio
10.5713.8467.8522.81-16.55
Debt / Equity Ratio
0.560.650.670.640.630.78
Debt / EBITDA Ratio
1.781.831.841.722.122.80
Debt / FCF Ratio
1.692.369.632.84-4.45
Net Debt / Equity Ratio
0.300.360.570.500.480.61
Net Debt / EBITDA Ratio
0.981.041.591.361.672.26
Net Debt / FCF Ratio
0.921.328.152.21-11.783.48
Asset Turnover
0.490.510.540.580.620.56
Inventory Turnover
1.972.012.132.132.653.45
Quick Ratio
1.301.631.851.171.160.88
Current Ratio
1.812.152.801.811.931.39
Return on Equity (ROE)
22.32%26.30%26.32%24.23%14.16%12.48%
Return on Assets (ROA)
9.09%10.57%10.16%10.47%7.71%5.73%
Return on Invested Capital (ROIC)
15.80%17.59%17.05%17.51%12.44%9.85%
Return on Capital Employed (ROCE)
18.20%19.50%17.90%18.00%15.00%11.70%
Earnings Yield
6.69%7.08%5.71%4.69%5.49%5.23%
FCF Yield
10.37%8.11%1.67%4.88%-1.77%7.82%
Dividend Yield
2.27%2.20%1.79%1.49%2.13%0.47%
Payout Ratio
32.12%24.32%22.07%16.75%6.56%-
Buyback Yield / Dilution
0.26%-0.53%-0.13%-1.95%-5.43%-0.65%
Total Shareholder Return
2.52%1.68%1.66%-0.46%-3.30%-0.18%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.